The role of hemoglobin concentration in the outcome of misonidazole-sensitized radiotherapy of head and neck cancers: Based on rtog trial #79-15
- 1 December 1989
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 17 (6), 1177-1181
- https://doi.org/10.1016/0360-3016(89)90523-3
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 studyInternational Journal of Radiation Oncology*Biology*Physics, 1989
- The influence of haemoglobin concentration on the response to radiotherapyScandinavian Journal of Clinical and Laboratory Investigation, 1988
- The significance of anemia in clinical radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Anemia: A problem or an opportunity in radiotherapy?International Journal of Radiation Oncology*Biology*Physics, 1986
- Primary radiotherapy of larynx and pharynx carcinoma—An analysis of some factors influencing local control and survivalInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Blood pressure and hemoglobin concentration: Multivariate analysis of local control after irradiation for head and neck cancerInternational Journal of Radiation Oncology*Biology*Physics, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958